Display options
Share it on

Med Clin (Barc). 2014 Dec;143:44-7. doi: 10.1016/S0025-7753(15)30010-5.

[Future challenges in multiple sclerosis].

Medicina clinica

[Article in Spanish]
Óscar Fernández

Affiliations

  1. Unidad de Gestión Clínica de Neurociencias, Servicio de Neurología, Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Málaga, España; Instituto de Investigación en Biomedicina de Málaga (IBIMA), Universidad de Málaga, Málaga, España. Electronic address: [email protected].

PMID: 25732950 DOI: 10.1016/S0025-7753(15)30010-5

Abstract

Multiple sclerosis occurs in genetically susceptible individuals, in whom an unknown environmental factor triggers an immune response, giving rise to a chronic and disabling autoimmune disease. Currently, significant progress is being made in our knowledge of the frequency and distribution of multiple sclerosis and its risk factors, genetics, pathology, pathogenesis, diagnostic and prognostic markers, and treatment. This has radically changed patients' and clinicians' expectations of multiple sclerosis and has raised hope that there will soon be a way to control the disease.

Copyright © 2014 Elsevier España, S.L.U. All rights reserved.

Keywords: Epidemiology; Epidemiología; Esclerosis múltiple; Genetics; Genética; Multiple sclerosis; Pathogenesis; Patogenia; Prognosis; Pronóstico; Tratamiento; Treatment

MeSH terms

Publication Types